EASTLAND JULIA MARIE
SEC Form 4 insider trading activity
EASTLAND JULIA MARIE has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including LNTH, ZNTL, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.
On the most recent filing, EASTLAND JULIA MARIE is listed as CEO & President at Zentalis Pharmaceuticals, Inc. Inside the rolling window, EASTLAND JULIA MARIE reported no open-market purchases and 2 open-market sales totaling $21K in ZNTL. The largest disclosed transaction in the window is a sale of 7,866 ZNTL shares on Feb 6, 2026, worth $19K.
Companies traded
Other insiders at LNTH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has EASTLAND JULIA MARIE made?
EASTLAND JULIA MARIE has filed 2 SEC Form 4 filings (3 transaction rows) across 2 companies, including LNTH, ZNTL since 2026.
Which companies does EASTLAND JULIA MARIE trade?
EASTLAND JULIA MARIE has filed SEC Form 4 disclosures for 2 companies, including LNTH, ZNTL.
When was EASTLAND JULIA MARIE's most recent SEC Form 4 filing?
EASTLAND JULIA MARIE's most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.
What is EASTLAND JULIA MARIE's total buy and sell value in the current window?
Inside the rolling retention window, EASTLAND JULIA MARIE bought $0 and sold $21K based on SEC Form 4 filings.
What was EASTLAND JULIA MARIE's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,866 ZNTL shares on 2026-02-06, worth $19K, per SEC Form 4 filings.